Vitrolife AB Statistics

Total Valuation

Vitrolife AB has a market cap or net worth of SEK 21.41 billion. The enterprise value is 22.31 billion.

Market Cap	21.41B
Enterprise Value	22.31B

Important Dates

The next estimated earnings date is Thursday, July 17, 2025.

Earnings Date	Jul 17, 2025
Ex-Dividend Date	Apr 30, 2025

Share Statistics

Vitrolife AB has 135.42 million shares outstanding. The number of shares has increased by 0.10% in one year.

Current Share Class	135.42M
Shares Outstanding	135.42M
Shares Change (YoY)	+0.10%
Shares Change (QoQ)	-0.21%
Owned by Insiders (%)	0.03%
Owned by Institutions (%)	65.70%
Float	75.04M

Valuation Ratios

The trailing PE ratio is 43.08 and the forward PE ratio is 31.61.

PE Ratio	43.08
Forward PE	31.61
PS Ratio	5.93
PB Ratio	1.63
P/TBV Ratio	n/a
P/FCF Ratio	31.26
P/OCF Ratio	27.52
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 18.58, with an EV/FCF ratio of 32.57.

EV / Earnings	44.80
EV / Sales	6.18
EV / EBITDA	18.58
EV / EBIT	28.82
EV / FCF	32.57

Financial Position

The company has a current ratio of 3.77, with a Debt / Equity ratio of 0.15.

Current Ratio	3.77
Quick Ratio	2.98
Debt / Equity	0.15
Debt / EBITDA	1.62
Debt / FCF	2.85
Interest Coverage	8.41

Financial Efficiency

Return on equity (ROE) is 3.78% and return on invested capital (ROIC) is 3.18%.

Return on Equity (ROE)	3.78%
Return on Assets (ROA)	2.89%
Return on Invested Capital (ROIC)	3.18%
Return on Capital Employed (ROCE)	4.83%
Revenue Per Employee	3.14M
Profits Per Employee	433,043
Employee Count	1,169
Asset Turnover	0.22
Inventory Turnover	3.64

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -10.82% in the last 52 weeks. The beta is 1.83, so Vitrolife AB's price volatility has been higher than the market average.

Beta (5Y)	1.83
52-Week Price Change	-10.82%
50-Day Moving Average	162.60
200-Day Moving Average	209.99
Relative Strength Index (RSI)	51.71
Average Volume (20 Days)	248,662

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Vitrolife AB had revenue of SEK 3.61 billion and earned 498.00 million in profits. Earnings per share was 3.67.

Revenue	3.61B
Gross Profit	2.14B
Operating Income	774.00M
Pretax Income	671.00M
Net Income	498.00M
EBITDA	1.15B
EBIT	774.00M
Earnings Per Share (EPS)	3.67

Full Income Statement

Balance Sheet

The company has 1.05 billion in cash and 1.95 billion in debt, giving a net cash position of -897.00 million or -6.62 per share.

Cash & Cash Equivalents	1.05B
Total Debt	1.95B
Net Cash	-897.00M
Net Cash Per Share	-6.62
Equity (Book Value)	13.13B
Book Value Per Share	96.92
Working Capital	1.67B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 778.00 million and capital expenditures -93.00 million, giving a free cash flow of 685.00 million.

Operating Cash Flow	778.00M
Capital Expenditures	-93.00M
Free Cash Flow	685.00M
FCF Per Share	5.06

Full Cash Flow Statement

Margins

Gross margin is 59.34%, with operating and profit margins of 21.44% and 13.80%.

Gross Margin	59.34%
Operating Margin	21.44%
Pretax Margin	18.59%
Profit Margin	13.80%
EBITDA Margin	31.91%
EBIT Margin	21.44%
FCF Margin	18.98%

Dividends & Yields

This stock pays an annual dividend of 1.10, which amounts to a dividend yield of 0.70%.

Dividend Per Share	1.10
Dividend Yield	0.70%
Dividend Growth (YoY)	10.00%
Years of Dividend Growth	2
Payout Ratio	27.11%
Buyback Yield	-0.10%
Shareholder Yield	0.60%
Earnings Yield	2.33%
FCF Yield	3.20%

Dividend Details

Stock Splits

The last stock split was on May 17, 2018. It was a forward split with a ratio of 5.

Last Split Date	May 17, 2018
Split Type	Forward
Split Ratio	5

Scores

Vitrolife AB has an Altman Z-Score of 5.17.

Altman Z-Score	5.17
Piotroski F-Score	n/a